HALO Halozyme Therapeutics, Inc.
Healthcare$68.72+0.59%ClosedMarket Cap: $8.15B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$75.00
Target (Median)
$75.00
Target Range
$56.00 - $95.00
Upside from current price: 9.1%
Rating Distribution
2 Strong Buy4 Buy3 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-04-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-19 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-02-19 | Benchmark | maintain | Buy | Buy |
| 2026-01-08 | TD Cowen | maintain | Buy | Buy |
| 2025-12-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-18 | Goldman Sachs | maintain | Neutral | Neutral |
| 2025-11-04 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-10-27 | JP Morgan | maintain | Neutral | Neutral |
| 2025-10-20 | Morgan Stanley | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.93 | $2.00B | 4 |
| Sun Dec 31 | $11.17 | $2.18B | 2 |
| Mon Dec 31 | $10.13 | $2.01B | 1 |
| Tue Dec 31 | $8.90 | $1.78B | 1 |